Molecular and genetic monitoring of clinical isolates of K. pneumoniae ST395 in the Russian Federation based on whole-genome sequencing data
https://doi.org/10.31631/2073-3046-2026-25-3-141-159
Abstract
Relevance. Globally disseminated genetic lineages of Klebsiella pneumoniae characterized by the presence and rapid acquisition of multiple antimicrobial resistance determinants and virulence factors are known as epidemic clones or clonal groups of high risk. At present, sequence type ST395 represents the predominant epidemic clone of K. pneumoniae circulating in the Russian Federation.
Aims. To investigate the genetic diversity of K. pneumoniae strains isolated in hospitals from different regions of the Russian Federation using whole-genome sequencing data, with particular emphasis on the dominant epidemic clone ST395.
Materials and Methods. Whole-genome sequencing data from 162 clinical K. pneumoniae isolates collected in six medical institutions located in Moscow, Barnaul, and Orenburg were analyzed.
Results. Among the 162 isolates examined, the most prevalent genetic lineage was ST395 (62/162; 38 %), which was detected in all participating hospitals. All analyzed K. pneumoniae isolates harbored a broad repertoire of genomic resistance determinants to at least nine classes of antibacterial agents, including aminoglycosides, beta-lactams (including carbapenems), phenicols, trimethoprim, fosfomycin, macrolides, fluoroquinolones, sulfonamides, and tetracyclines. A substantial proportion of ST395 isolates (77.7 %, 49/63) carried combinations of three or more distinct betalactamase genes, and the most interesting fact was the co-occurrence of blaNDM with blaCTX and blaTEM. Phylogenetic analysis demonstrated the formation of several clusters comprising isolates from different medical institutions. Isolates from one hospital in Moscow and one isolate from Barnaul were assigned to the same epidemic clone.
Conclusion. Genomically closely related, and in some cases apparently identical, strains were identified in geographically distant medical institutions. These findings underscore the importance of assigning isolates to epidemic clones, as such classification enables a more accurate assessment of their epidemic potential.
About the Authors
E. A. DymentRussian Federation
Elizaveta A. Dyment – Junior Researcher, Laboratory of Molecular Mechanisms of Antibiotic Resistance, Department of Molecular Diagnostics and Epidemiology
31, Prospect Budennogo, Moscow, 105275
+7 (915) 094-53-61
A. A. Shelenkov
Russian Federation
Andrey A. Shelenkov – Cand. Sci. (Physics and Mathematics), Senior Researcher, Laboratory of Molecular Mechanisms of Antibiotic Resistance, Department of Molecular Diagnostics and Epidemiology
Moscow
L. V. Petrova
Russian Federation
Ludmila V. Petrova – doctor-bacteriologist, head of the microbiological laboratory
Moscow
V. G. Gusarov
Russian Federation
Vitally G. Gusarov – Cand. Sci. (Med.)
Moscow
M. N. Zamyatin
Russian Federation
Mikhail N. Zamyatin – Dr. Sci. (Med.), Professor, Head of Department of Anesthesiology and Intensive Care Medicine
Moscow
N. V. Sycheva
Russian Federation
Natalya V. Sycheva – researcher, laboratory of infections associated with the provision of medical care
Moscow
A. V. Tutelyan
Russian Federation
Aleksej V. Tutelyan – Corresponding Member of the RAS, Dr. Sci. (Med.), Head of the laboratory of infections associated with the provision of medical care
Moscow
Yu. V. Mikhailova
Russian Federation
Yuliya V. Mikhailova – Cand. Sci. (Biol.), Head of Laboratory of Molecular Mechanisms of Antibiotic Resistance, Department of Molecular Diagnostics and Epidemiology
Moscow
V.G. Akimkin
Russian Federation
Vasily G. Akimkin –the RAS Academician, Dr. Sci. (Med.), Professor, Director of Central Research Institute for Epidemiology
Moscow
References
1. Belotserkovskiy B.Z., Kruglov A.N., Ni O.G., et al. Etiological structure of infections in patients of the surgical intensive care unit in the post-covid era. Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26:124–40. [In Russ.] DOI: https://doi.org/10.36488/cmac.2024.2.124-140
2. Sati H, Carrara E, Savoldi A, et al. The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis. 2025; 25:1033–43. DOI: https://doi.org/10.1016/S1473-3099(25)00118-5
3. Chebotar I.V., Bocharova YA, Podoprigora IV, et al. The reasons why Klebsiella pneumoniae becomes a leading opportunistic pathogen. Clinical microbiology and antimicrobial chemotherapy. 2020; 22:4–19. [In Russ.] DOI: 10.36488/cmac.2020.1.4-19
4. European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual Epidemiological Report 2023. Stockholm: ECDC; 2024. – URL: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-eueea-ears-net-annual-epidemiological-report-2023 (accessed: 20.07.2026).
5. Kuzmenkov A.Yu., Vinogradova A.G., Trushin I.V., et al. AMRmap – antibiotic resistance surveillance system in Russia. Clinical microbiology and antimicrobial chemotherapy. 2021; 23:198–204. [In Russ.] DOI: https://doi.org/10.36488/cmac.2021.2.198-204
6. Ageevets VA, Ageevets IV, Sidorenko SV. Convergence of multiple resistance and hypervirulence in Klebsiella pneumoniae. Russian Journal of Infection and Immunity. 2022; 12:450–60. [In Russ.] DOI: https://doi.org/10.15789/2220-7619-COM-1825
7. Diancourt L, Passet V, Verhoef J, et al. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005; 43:4178–82. DOI: https://doi.org/10.1128/JCM.43.8.4178-4182.2005
8. Arcari G, Carattoli A. Global spread and evolutionary convergence of multidrug-resistant and hypervirulent Klebsiella pneumoniae high-risk clones. Pathog Glob Health. 2023 ; 117:328–41. DOI: https://doi.org/10.1080/20477724.2022.2121362
9. Goncharov AE. Molecular and genetic monitoring of epidemic clones of Staphylococcus aureus and Acinetobacter baumannii in the system of epidemiological surveillance of hospital-acquired infections, PhD. St. Petersburg; 2016. [In Russ.]
10. Shelenkov A, Slavokhotova A, Mikhaylova Y, Akimkin V. Genomic typing, antimicrobial resistance gene, virulence factor and plasmid replicon database for the important pathogenic bacteria Klebsiella pneumoniae. BMC Microbiol. 2025; 25:3. DOI: https://doi.org/10.1186/s12866-024-03720-8
11. Edelstein M.V., Shajdullina E.R., Ivanchik N.V., et al. Antimicrobial resistance of clinical isolates of Klebsiella pneumoniae and Escherichia coli in Russian hospitals: results of a multicenter epidemiological study. Clinical microbiology and antimicrobial chemotherapy. 2024; 26:67–78. [In Russ.] DOI: https://doi.org/10.36488/cmac.2024.1.67-78
12. MR 3.1.0346-24. 3.1. Epidemiology. Prevention of infectious diseases. Organization and conduct of microbiological monitoring in medical organizations. Methodological recommendations (approved by the Chief State Sanitary Doctor of the Russian Federation on 26.04.2024). – URL: https://sudact.ru/law/mr-310346-24-31-epidemiologiiaprofilaktika-infektsionnykh-boleznei/ (accessed: 20.07.2026). [In Russ.]
13. Shelenkov A, Mikhaylova Y, Voskanyan S, Egorova A, Akimkin V. Whole-Genome Sequencing Revealed the Fusion Plasmids Capable of Transmission and Acquisition of Both Antimicrobial Resistance and Hypervirulence Determinants in Multidrug-Resistant Klebsiella pneumoniae Isolates. Microorganisms. Multidisciplinary Digital Publishing Institute; 2023; 11. DOI: https://doi.org/10.3390/microorganisms11051314
14. Feijao P, Yao H-T, Fornika D, et al. MentaLiST – A fast MLST caller for large MLST schemes. Microbial Genomics. 2018; Feb;4(2):e000146. doi: 10.1099/mgen.0.000146.
15. Schürch AC, Arredondo-Alonso S, Willems RJL, et al. Whole genome sequencing options for bacterial strain typing and epidemiologic analysis based on single nucleotide polymorphism versus gene-by-gene–based approaches. Clinical Microbiology and Infection. 2018; 24:350–4. DOI: https://doi.org/10.1016/j.cmi.2017.12.016
16. Shelenkov A, Slavokhotova A, Mikhaylova Y, Akimkin V. Genomic typing, antimicrobial resistance gene, virulence factor and plasmid replicon database for the important pathogenic bacteria Klebsiella pneumoniae. BMC Microbiol. 2025; 25:3. DOI: https://doi.org/10.1186/s12866-024-03720-8
17. Raherison S, Jove T, Gaschet M, et al. Expression of the aac(6’)-Ib-cr Gene in Class 1 Integrons. Antimicrob Agents Chemother. 2017; 61:e02704–16. DOI: https://doi.org/10.1128/AAC.02704-16
18. Huang J, Zhang S, Zhao Z, et al. Acquisition of a Stable and Transferable blaNDM-5-Positive Plasmid With Low Fitness Cost Leading to Ceftazidime/Avibactam Resistance in KPC-2-Producing Klebsiella pneumoniae During Treatment. Front Cell Infect Microbiol. Frontiers; 2021; 11. DOI: https://doi.org/10.3389/fcimb.2021.658070
19. Le V, Nhu NTK, Cerdeno-Tarraga A, et al. Genetic characterization of three qnrS1-harbouring multidrug-resistance plasmids and qnrS1-containing transposons circulating in Ho Chi Minh City, Vietnam. J Med Microbiol. 2015; 64:869–78. DOI: https://doi.org/10.1099/jmm.0.000100
20. Lian J, Li Q, Peng C, et al. Molecular and epidemiological characterization of carbapenem-resistant hypervirulent Klebsiella pneumoniae in Huaian, China (2022-2024): a retrospective study. Front Cell Infect Microbiol. 2025; 15:1569004. DOI: https://doi.org/10.3389/fcimb.2025.1569004
21. Briko NI, Brusina EB, Zueva LP, et al. The Hospital Strain - аn Unknown Reality. Epidemiology and Vaccinal Prevention. 2013;30–5. [In Russ.]
22. Shaidullina ER, Schwabe M, Rohde T, et al. Genomic analysis of the international high-risk clonal lineage Klebsiella pneumoniae sequence type 395. Genome Med. 2023; 15:9. DOI: https://doi.org/10.1186/s13073-023-01159-6
23. Edelstein M.V., Shajdullina E.R., Ivanchik N.V., et al. Antimicrobial resistance of clinical isolates of Klebsiella pneumoniae and Escherichia coli in Russian hospitals: results of a multicenter epidemiological study. Clinical microbiology and antimicrobial chemotherapy. 2024; 26:67–78. [In Russ.] DOI: https://doi.org/10.36488/cmac.2024.1.67-78
24. Mathers AJ, Peirano G, Pitout JDD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev. 2015; 28:565–91. DOI: https://doi.org/10.1128/CMR.00116-14
25. Pay G.V., Rakitina D.V., Sukhina M.A., et al. Study of the relationship between antibiotic resistance markers and virulence markers in NDM-positive Klebsiella pneumoniae strains circulating in various waters and human loci. Hygiene and Sanitation. 2021;100(12):1366–1371. [In Russ.] https://doi.org/10.47470/0016-9900-2021-100-12-1366-1371
26. Shelenkov A, Mikhaylova Y, Yanushevich Y, et al. Molecular Typing, Characterization of Antimicrobial Resistance, Virulence Profiling and Analysis of Whole-Genome Sequence of Clinical Klebsiella pneumoniae Isolates. Antibiotics (Basel). 2020; 9:261. DOI: https://doi.org/10.3390/antibiotics9050261
27. Le T, Wang L, Zeng C, et al. Clinical and microbiological characteristics of nosocomial, healthcare-associated, and community-acquired Klebsiella pneumoniae infections in Guangzhou, China. Antimicrob Resist Infect Control. 2021; 10:41. DOI: https://doi.org/10.1186/s13756-021-00910-1
28. Wang B, Farhan MHR, Yuan L, et al. Transfer dynamics of antimicrobial resistance among gram-negative bacteria. Science of The Total Environment. 2024; 954:176347. DOI: https://doi.org/10.1016/j.scitotenv.2024.176347
29. Skachkova T.S., Shipulina O.Yu., Shipulin G.A., et al. Characterization of genetic diversity of the Klebsiella pneumoniae strains in a Moscow tertiary care center using nextgeneration sequencing. Clinical microbiology and antimicrobial chemotherapy. 2019; 21:69–74. [In Russ.] DOI: https://doi.org/10.36488/cmac.2019.1.69-74
30. Arcari G, Carattoli A. Global spread and evolutionary convergence of multidrug-resistant and hypervirulent Klebsiella pneumoniae high-risk clones. Pathog Glob Health. 2023; 117:328–41. DOI: https://doi.org/10.1080/20477724.2022.2121362
31.
Review
For citations:
Dyment E.A., Shelenkov A.A., Petrova L.V., Gusarov V.G., Zamyatin M.N., Sycheva N.V., Tutelyan A.V., Mikhailova Yu.V., Akimkin V. Molecular and genetic monitoring of clinical isolates of K. pneumoniae ST395 in the Russian Federation based on whole-genome sequencing data. Epidemiology and Vaccinal Prevention. 2026;25(3):141-159. (In Russ.) https://doi.org/10.31631/2073-3046-2026-25-3-141-159
JATS XML






























